What is Zelira Therapeutics Limited?
Zelira Therapeutics Limited, a biopharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
Zelira Therapeutics Limited, a biopharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States. It offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops ZENIVOL, a cannabinoid drug for the treatment of chronic insomnia. The company is listed on the OTCQB in USA, operating in the Healthcare sector, with a market capitalisation of 5.75M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.